AA, B. K., I, Z., D, B., M, G., G, K., S, M., . . . M, B. A. (2024). Immunogenicity and Tolerance of BNT162b2 mRNA Vaccine in Allogeneic Hematopoietic Stem Cell Transplant Patients. Vaccines, 12(2), . https://doi.org/10.3390/vaccines12020174
Chicago Style (17th ed.) CitationAA, Ben Khlil, et al. "Immunogenicity and Tolerance of BNT162b2 MRNA Vaccine in Allogeneic Hematopoietic Stem Cell Transplant Patients." Vaccines 12, no. 2 (2024). https://doi.org/10.3390/vaccines12020174.
MLA (9th ed.) CitationAA, Ben Khlil, et al. "Immunogenicity and Tolerance of BNT162b2 MRNA Vaccine in Allogeneic Hematopoietic Stem Cell Transplant Patients." Vaccines, vol. 12, no. 2, 2024, https://doi.org/10.3390/vaccines12020174.
Warning: These citations may not always be 100% accurate.